The overall goal of HOPA's education program is to equip oncology pharmacy practitioners with knowledge about current developments and to improve the efficiency of healthcare delivery while maintaining or exceeding the quality of patient care.
In addition to the flagship HOPA Annual Conference, HOPA presents regional conference programming across the country that offer a variety of in-depth clinical education, practice management, and BCOP Recertification offerings.
Welcome to the all-new HOPA Resource Library where we consider all searches “advanced searches.”
The HOPA Health Policy and Advocacy committee is dedicated to acting as an advocate on behalf of patients as well as representing hematology/oncology pharmacists across the country in legislative and regulatory endeavors.
HOPA is an active and engaged organization that provides crucial education, networking, cutting edge resources and advancement opportunities to our members. Find yourself in HOPA.Join or renew your membership today!
We are pleased to share that research presented at the 2014 HOPA Annual Conference by members Jennifer L Niccolai, PharmD and Danielle L Roman, PharmD, has been published in a recent Journal of Oncology Practice.Read it all here!
Call for Volunteers for members to serve as expert contributors for the creation of a HOPA standard on oral chemotherapy.
Committee Restructure Orientation – Webinar Recording – This webinar will introduce you to the new HOPA committee structure
View recorded virtual conference sessions before April 30 and earn up to 15.25 CE credits.
Submit a letter of intent (LOI) for the 2017 HOPA Research Award – Deadline is May 24, 2017.
Palbociclib (IBRANCE®, Pfizer Inc.) approved for treatment of hormone receptor (HR) positive, human epidermal growth factor receptor...
Osimertinib (TAGRISSO®, AstraZeneca Pharmaceuticals, LP) approved for treatment of patients with metastatic epidermal growth factor receptor...
Niraparib (ZEJULA™, Tesaro, Inc.), approved for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian...
Avelumab (BAVENCIO, EMD Serono, Inc.) approved for treatment of adults and pediatric patients 12 years and older with metastatic...
Registration is open.
BCOP Programming: Specialty Sessions & Updates Course
HOPA Oncology Pharmacy Practice Management Program
Now pharmacists can fulfill all of their BCOP recertification education with HOPA— the experts in clinical oncology pharmacy. HOPA recently was awarded status as a BCOP recertification credit provider by the Board of Pharmacy Specialties (BPS), and will now provide 38 credits of education per year in a variety of delivery options.
The HOPA BCOP recertification courses address the four Domains of Oncology Pharmacy Specialty Practice and improve your knowledge and problem-solving skills in each area. These courses provide BCOP-specific assessments for practicing clinical oncology pharmacists with a need for specific disease prevention and treatment knowledge and strategies.Learn More
HOPA has created several patient education videos for you to share with your patients and their families.